Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
13F Institute Ownership
Total Institutes of 426 in Intra-Cellular Therapies expanded their positions with an increase of 28 investors compared to the previous quarter. A reduction of 1.57M shares, as total invested capital grew by $5.8B with ownership percentage increasing from 91.49% to 92.31%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 0.831
0.83
Call Flow 2,240,600
55%
Put Flow 1,862,178
45%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Vanguard Group Inc | 9.23% | 9.52M | -2.07% | 1.26B | 0.02% | May 09, 2025 |
| Blackrock, Inc. | 8.49% | 8.75M | +43.23% | 1.15B | 0.02% | May 02, 2025 |
| Pentwater Capital Management L... | 5.03% | 5.19M | +100.00% | 684.66M | 5.75% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.